By Ovid Therapeutics
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Ovid Therapeutics is a company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Hosted by Amit Rakhit, MD, MBA, this is our podcast. This is Bold Medicine.
||CleanPaul Melmeyer / Rare Disease Day||We're back, and there's no better time to kick off the 2019 season of BoldMedicine. February 28th is Rare Disease Day! Throughout the month of February hundreds of patient organizations from countries all over the world will hold awareness-raising acti.||2/11/2019||Free||View in iTunes|
||CleanTerry Jo Vetters Bichell||Terry Jo Vetters Bichell has been the Director/Scientific Officer of the Angelman Biomarkers and Outcome Measures Alliance (A-BOM) since its inception in 2016. Dr. Bichell earned a PhD in neuroscience from Vanderbilt University in 2016,||9/7/2018||Free||View in iTunes|
||CleanBecky Burdine / Bold Move||Becky Burdine impacts the rare disease community, the Angelman syndrome community and the scientific community in every way possible. Her approach is science driven and starts with the families in her community. Dr.||8/14/2018||Free||View in iTunes|
||CleanGlobal Genes||Amit speaks with Kendall James-Davis, Senior Manager of Strategic Alliances at Global Genes, about the impact of patient involvement in discovery. Kendall talks about the remarkable team of advocates at Global Genes dedicated to supporting families aff.||5/11/2018||Free||View in iTunes|
||CleanSam and Alexis Maydew||Amit is joined by Sam and Alexis Maydew, parents of a child with Angelman Syndrome. The Maydew's talk about their journey as parents, advocates and leaders in the Angelman Syndrome community.||4/30/2018||Free||View in iTunes|
||CleanThe Cute Syndrome Foundation||Amit talks with Hillary Savoie, Founder of The Cute Syndrome Foundation. Hillary shares her journey as a parent and rare epilepsy community leader.||3/21/2018||Free||View in iTunes|
||CleanWelcome to Ovid||In the first episode we introduce our host, Dr. Amit Rakhit, MD, MBA. Amit talks about the core philosophy that makes Ovid Therapeutics different in our approach. Amit also shares a remarkable story that inspires him to come to work every single day --.||2/7/2018||Free||View in iTunes|
||CleanWhy We Do What We Do||Amit introduces Chief Scientific Officer and Founder, Matthew During, M.D., D.Sc., and core members of the Ovid Research team. Matt, Melanie, Toshiya, and Amit talk about the diverse science-driven Ovid family,||2/5/2018||Free||View in iTunes|
||CleanLennox-Gastaut Syndrome||Founder of the Lennox-Gastaut Syndrome Foundation, Christina Sanlnocecio, talks about innovative programs available for LGS patients and families. This incredible foundation is driving science and supporting every patient and family affected by Lennox-.||2/5/2018||Free||View in iTunes|
||CleanChelsea Leyland||Chelsea Leyland shares her story of growing up with Juvenile Myclonic Epilepsy. Chelsea talks about her battle with rare epilepsy and the need to remove stigmas attached to the disease. In this episode we talk about what it's like to watch a loved one .||2/5/2018||Free||View in iTunes|
||CleanNORD Summit and Dr. Google||A hot topic at this year's National Organization for Rare Disorders (NORD) Summit was patient access to medication. In our patient-centric quick fire challenge, Amit tells us about the perfect patient partner.||2/5/2018||Free||View in iTunes|
Bold medicine indeed
This is a fantastic resource. Very helpful. Provides lots of innovative info on how access to patient-centered drug development should be.
Get to know a new type pharma company
The tide is turning and innovators are having their day as pharma is earning a new reputation that is patient centric. I appreciated the candor and access to the CMO and his ability to communicate what is truly important and possible when putting the patient first. Hope more pharma companies become this transparent...